SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NAMN - Nano Mask, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: xcentral11/12/2012 3:57:12 PM
   of 50
 
Nano Mask Issues Corporate Update

FISHKILL, N.Y., Jan. 12, 2012 /PRNewswire via COMTEX/ -- Nano Mask, Inc. (NMI) (Pinksheets: NANM), a materials technology development company focused on health and wellness related markets, today issued the following corporate update:
X-STATIC?- Infection Prevention Textiles(TM)

NMI, in conjunction with its strategic partner Noble Biomaterials, Inc., has developed a host of new products incorporating Noble's X-STATIC? silver antimicrobial technology. X-STATIC? is clinically proven to eliminate 99% of bacteria directly on the fabrics, providing comprehensive, continuous and permanent antimicrobial protection.

Hospital acquired infection is a major problem worldwide and by offering a whole suite of products to combat this problem, NMI is positioning itself to be a participant in this rapidly growing market. Fabrics made with X-STATIC? fibers are flexible, with the natural look and feel of traditional textiles, while offering all the benefits of pure silver. The product line consists of professional and patient wear, bed linens, cubical curtains and customized window and wall coverings. The products are now available globally.

RespAide(TM)

NMI will reintroduce RespAide, a state-of-the-art cardio-pulmonary resuscitation (CPR) mask, to the market. RespAide is designed to minimize the potential for transmission of contagious diseases during the administration of CPR and has been granted FDA 510K approval as a Class II medical device. NMI has contracted an Arizona-based company to manufacture the product and has been taking pre-orders for the product from both U.S. and international customers. NMI expects to formally relaunch RespAide in February 2012.

SEC Reporting Progress

NMI has been diligently working to bring its Securities and Exchange Commission filings current and expects to achieve this objective by the end of January 2012.

Sales

In the last six months of 2011 NMI received purchase orders of approximately $ 500,000 and shipped approximately $ 250,000 of product; most of the balance of the purchase orders is expected to ship within the next 30 days. The products on which purchase orders have been received are: products powered by X-STATIC antimicrobial fabric technology, enzymatic detergents, N99 ViraMask, RespAide and disposable cubicle curtains.

About Nano Mask, Inc. (http://nmihealth.com)We are a healthcare product development and distribution company providing innovative and cost effective emergency and critical care and infection control products to a variety of market segments within the healthcare industry. Our customers range from hospitals, emergency services, surgery centers, long-term care facilities, nursing homes and other clinical settings throughout the healthcare continuum. Today, the fundamental principles that guided the development of our emergency and critical care products through to our infection control products remain a constant. They define our commitment to developing products that function the way they are intended, are manufactured to the very highest standards, achieve benchmark levels of performance, inspire confidence with their use, protect the health of those who use them and ultimately save lives.

About Noble Biomaterials, Inc. (www.InfectionPreventionTextiles.com)Noble Biomaterials, Inc. is a global leader in bacterial management solutions. Noble develops, manufactures, sells and markets advanced antimicrobial technologies designed to manage all forms of bacterial contamination for medical, defense, industrial and consumer markets.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext